Security researchers cracked a MediaTek-powered Nothing CMF Phone 1 in 45 seconds, exposing a vulnerability that potentially ...

Unlike previous Wi-Fi attacks, AirSnitch exploits core features in Layers 1 and 2 and the failure to bind and synchronize a ...

Over the past decade, Don’t Nod has explored the soul-sucking worlds of 17th-century America, post-WWI London, dystopian Paris, and a high school in the Pacific Northwest. But for its next trick, the ...

Real estate agents will tell you that a home’s most important feature is “location, location, location.” It’s similar in neuroscience: “Location is everything in the brain,” said Bosiljka Tasic, a ...

Tesla Inc (NASDAQ: TSLA) is moving quickly to turn Elon Musk's massive solar vision into reality, as the company ramps up plans for U.S.-based solar cell manufacturing alongside its broader AI and ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Illumina became a genomics juggernaut by developing machines that could read large ...

A federal judge in San Diego has denied a request from attorneys in a class-action lawsuit to bar the Sheriff’s Office from housing people with serious mental illness in administrative separation, a ...

Ridley Scott's inimitable 1979 sci-fi thriller, Alien, expertly ratchets up the tension by not having the titular alien show up on screen until roughly an hour into the film. Following in Scott's ...

A Texas teenager was rescued by her father after she was forced into a truck at knifepoint on Christmas Day, police said. Patrol deputies with the Montgomery County Sheriff's Office were called to an ...

TL;DR: 20th Century Fox reportedly greenlit a new Alien franchise game, potentially developed by Eidos Montreal, known for Deus Ex and Tomb Raider. This singleplayer horror-survival title emphasizes ...

At its annual Ecosystem Day on December 12, Hithium Energy Storage signaled a strategic improvement beyond conventional four-hour batteries, positioning long-duration storage as both a grid asset and ...

The ongoing phase I/II clinical trial is evaluating the safety, tolerability and early efficacy signals of Aleta’s first-in-class biologic CAR T-cell engager, ALETA-001 Preliminary findings include a ...